Lemtrada and Swallowing difficulty - a phase IV clinical study of FDA data
Summary:
Swallowing difficulty is reported as a side effect among people who take Lemtrada (alemtuzumab), especially for people who are female, 40-49 old, have been taking the drug for < 1 month also take Benadryl, and have Multiple sclerosis.
The phase IV clinical study analyzes which people have Swallowing difficulty when taking Lemtrada. It is created by eHealthMe based on reports of 8,297 people who have side effects when taking Lemtrada from the FDA, and is updated regularly.
What is Lemtrada?
Lemtrada has active ingredients of alemtuzumab. eHealthMe is studying from 8,317 Lemtrada users. Check the latest studies of Lemtrada.
What is Swallowing difficulty?
Swallowing difficulty is found to be associated with 2,400 drugs and 3,353 conditions by eHealthMe. Check the latest studies of Swallowing difficulty.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
8,297 people reported to have side effects when taking Lemtrada.
Among them, 102 people (1.23%) have Swallowing difficulty.
Among these 102 people:
How long have people been on Lemtrada when they have Swallowing difficulty? *
What is the gender of people who have Swallowing difficulty when taking Lemtrada? *
What is the age of people who have Swallowing difficulty when taking Lemtrada? *
What are other drugs people take besides Lemtrada? *
What are other side effects people have besides Swallowing difficulty? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Lemtrada and have Swallowing difficulty?
- Check whether Swallowing difficulty is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Lemtrada:
- Lemtrada (8,317 reports)
Swallowing difficulty treatments and more:
- Swallowing difficulty (112,312 reports)
How severe was Swallowing difficulty and when was it recovered:
Expand to all the drugs that have ingredients of alemtuzumab:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Lemtrada:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Swallowing difficulty:
- Swallowing difficulty (2,400 drugs)
Browse all the conditions that are associated with Swallowing difficulty:
- Swallowing difficulty (3,353 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on alemtuzumab (the active ingredients of Lemtrada) and Lemtrada (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Vaginal Discharge and drugs of ingredients of l-ascorbic acid - now
- Imuran and Pain In Jaw for Men aged 60+ - 2 seconds ago
- Metformin and Melatonin drug interactions for men aged 50-59 - 7 seconds ago
- Type 2 Diabetes and Acute Pulmonary Oedema - 10 seconds ago
- Heart Attack and drugs of ingredients of aprepitant - 11 seconds ago
- Phentermine and Premarin drug interactions for women aged 50-59 - 15 seconds ago
- Hot Flush and drugs of ingredients of ipilimumab - 17 seconds ago
- Drug interactions of Septra Ds and Tylenol - 18 seconds ago
- Drug interactions of Prilosec Otc and Psyllium - 19 seconds ago
- Ativan and Ampyra drug interactions for women aged 60+ - 20 seconds ago